首页> 外文期刊>Urology >Tamsulosin reduces the incidence of acute urinary retention following early removal of the urinary catheter after radical retropubic prostatectomy.
【24h】

Tamsulosin reduces the incidence of acute urinary retention following early removal of the urinary catheter after radical retropubic prostatectomy.

机译:坦索罗辛降低了根治性耻骨后前列腺切除术后提早拔除导尿管后急性尿retention留的发生率。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To determine the efficacy of tamsulosin in preventing acute urinary retention following early catheter removal after radical retropubic prostatectomy. METHODS: Between February 2000 and October 2000, cystography was performed on postoperative day 7 after radical retropubic prostatectomy by a single surgeon (group 1). Between September 2001 and August 2002, cystography was performed on postoperative day 8 after radical retropubic prostatectomy by the same surgeon (group 2). The protocol for performing cystography and assessment of extravasation was similar for both groups. Tamsulosin 0.4 mg was administered 3 days before and 4 days after cystography for all men in group 2. RESULTS: Of 179 cystograms in group 1, 135 (75%) revealed no extravasation, and the catheters were removed in 130 of these cases. Of 246 cystograms in group 2, 230 (93.5%) revealed no extravasation, and the catheters were removed in 229 of these cases. A significantly greater proportion of men in group 2 had no extravasation (P = 0.0007). The incidence of acute urinary retention in groups 1 and 2 was 10% and 2.6%, respectively (P = 0.0018). The incidence of anastomotic stricture was not significantly different between the two groups. CONCLUSIONS: Our data strongly suggest that tamsulosin significantly reduces the risk of acute urinary retention after attempts at early catheter removal following radical retropubic prostatectomy. Therefore, we recommend administering a 7-day course of tamsulosin therapy when attempting to remove the urinary catheter before postoperative day 8.
机译:目的:确定坦索罗辛预防根治性耻骨后前列腺切除术后及早拔除导管后急性尿retention留的功效。方法:在2000年2月至2000年10月之间,由一名外科医生(第1组)在耻骨后前列腺癌根治术后第7天进行了膀胱造影。在2001年9月至2002年8月之间,由同一位外科医生(第2组)在耻骨后前列腺癌根治术后第8天进行了膀胱造影。两组进行膀胱造影和外渗评估的方案相似。第2组所有男性在膀胱造影术前3天和术后4天服用坦索罗辛0.4 mg。结果:在第1组的179例膀胱造影图中,有135例(75%)未发现渗出,并且在130例中移除了导管。在第2组的246例膀胱造影中,有230例(93.5%)没有渗出,并且在229例中移除了导管。第2组中有较大比例的男性没有外渗(P = 0.0007)。第1组和第2组的急性尿retention留发生率分别为10%和2.6%(P = 0.0018)。两组吻合口狭窄的发生率无显着差异。结论:我们的数据强烈表明坦索罗辛可显着降低尝试行根治性耻骨后前列腺切除术后早期拔除导管后发生急性尿retention留的风险。因此,我们建议在术后第8天之前尝试拔除导尿管时,进行坦索罗辛治疗的7天疗程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号